Details for New Drug Application (NDA): 205576
✉ Email this page to a colleague
The generic ingredient in PROPOFOL is propofol. There are twelve drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the propofol profile page.
Summary for 205576
Tradename: | PROPOFOL |
Applicant: | Innopharma |
Ingredient: | propofol |
Patents: | 0 |
Pharmacology for NDA: 205576
Physiological Effect | General Anesthesia |
Medical Subject Heading (MeSH) Categories for 205576
Suppliers and Packaging for NDA: 205576
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PROPOFOL | propofol | INJECTABLE;INJECTION | 205576 | ANDA | Pfizer Laboratories Div Pfizer Inc | 0069-0209 | 0069-0209-10 | 10 VIAL in 1 CARTON (0069-0209-10) / 20 mL in 1 VIAL (0069-0209-01) |
PROPOFOL | propofol | INJECTABLE;INJECTION | 205576 | ANDA | Pfizer Laboratories Div Pfizer Inc | 0069-0234 | 0069-0234-20 | 20 VIAL in 1 CARTON (0069-0234-20) / 50 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/ML | ||||
Approval Date: | Sep 16, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription